CHCHD2

protein-coding

coiled-coil-helix-coiled-coil-helix domain containing 2, the group of Coiled-coil-helix-coiled-coil-helix domain containing proteins

Gene summary

The protein encoded by this gene belongs to a class of eukaryotic CX(9)C proteins characterized by four cysteine residues spaced ten amino acids apart from one another. These residues form disulfide linkages that define a CHCH fold. In response to stress, the protein translocates from the mitochondrial intermembrane space to the nucleus where it binds to a highly conserved 13 nucleotide oxygen responsive element in the promoter of cytochrome oxidase 4I2, a subunit of the terminal enzyme of the electron transport chain. In concert with recombination signal sequence-binding protein J, binding of this protein activates the oxygen responsive element at four percent oxygen. In addition, it has been shown that this protein is a negative regulator of mitochondria-mediated apoptosis. In response to apoptotic stimuli, mitochondrial levels of this protein decrease, allowing BCL2-associated X protein to oligomerize and activate the caspase cascade. Pseudogenes of this gene are found on multiple chromosomes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]

Previous symbols:
  • C7orf17

MANE transcript

NM_016139.4

Inheritance

AD

ClinVar variants

P:1U:68B:13

Top phenotype

Parkinson disease 22, autosomal dominant

gnomAD constraint

pLI —, LoF o/e 1.36

Max pathogenic AF

—

Genomic locus

chr7:56,094,567-56,106,479

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~11.9 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

Parkinson disease 22, autosomal dominantSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0014742

Submitter: Labcorp Genetics (formerly Invitae)

Parkinson disease 22, autosomal dominantSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0014742

Submitter: Genomics England PanelApp

Clinical Genomic Database (CGD)

Parkinson disease 22, autosomal dominantAD

Manifestation: Neurologic

Intervention: Neurologic

Rationale: Response to levodopa has been described

Refs: 25662902Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to CHCHD2 variants in ClinVar

5 Conditions Cataloged
not providedTotal: 75
not specifiedTotal: 20
Parkinson disease 22, autosomal dominantTotal: 5
CHCHD2-related disorderTotal: 5
Amelogenesis imperfectaTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_016139.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
10
clinvar
11
missense
1
clinvar
62
clinvar
2
clinvar
1
clinvar
66
nonsense
1
clinvar
1
start loss
0
frameshift
2
clinvar
2
splice donor/acceptor (+/-2bp)
2
clinvar
2
Total106812182

Highest pathogenic variant AF is 0.000008222738

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 31 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_016139.4RefSeqNP_057223.14MANE Select
ENST00000395422.4EnsemblENSP00000378812.34MANE Select
NM_001320327.2RefSeqNP_001307256.14Standard
ENST00000716930.1EnsemblENSP00000520614.13Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Metabolism of proteins
  • Mitochondrial protein import

Biological Process

  • mitochondrion organization
  • positive regulation of transcription by RNA polymerase II
  • regulation of cellular response to hypoxia

Molecular Function

  • protein binding
  • transcription factor binding
  • sequence-specific DNA binding

Cellular Component

  • nucleus
  • mitochondrion
  • mitochondrial intermembrane space

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000395422
Coding exons
4
Length
5008
Individuals with no LoFs
125732
Homozygous LoFs
0
Heterozygous LoFs
15
Defined
125747
p
0.0000596
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.1218891.30.9640.00000484950
Missense (PolyPhen)1420.7250.67553265
Synonymous0.4683235.50.9000.00000202329
Loss of Function-0.85596.631.362.88e-767

Population LoF Frequency

PopulationCAFp-valueStatus
African00.0absent
Latino/Admixed American0.0000290.000029rare
Ashkenazi Jewish00.0absent
East Asian0.000160.00016rare
Finnish00.0absent
European (Non-Finnish)0.0000790.000079rare
South Asian0.0000650.000065rare
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Transcription factor. Binds to the oxygen responsive element of COX4I2 and activates its transcription under hypoxia conditions (4% oxygen), as well as normoxia conditions (20% oxygen) (PubMed:23303788). {ECO:0000269|PubMed:23303788}.;
Disease
DISEASE: Parkinson disease 22 (PARK22) [MIM:616710]: An autosomal dominant form of Parkinson disease, a complex neurodegenerative disorder characterized by bradykinesia, resting tremor, muscular rigidity and postural instability, as well as by a clinically significant response to treatment with levodopa. The pathology involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain. {ECO:0000269|PubMed:25662902}. Note=The gene represented in this entry may be involved in disease pathogenesis.;

Recessive Scores

pRec
0.100

Intolerance Scores

LoFtool
0.686
RVIS EVS
-0.12
RVIS percentile EVS
44.54

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
S
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.942

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.